Coffee & Cases Episode 5: A Walk in Their Shoes

Defining RNA signatures associated with graft tolerance may also provide the opportunity to identify new biological markers or therapeutic targets in this process and allow for the personalization of immunosuppressant therapy Impact and clinical application. The combined power of high-throughput next-generation RNA sequencing and deep learning enables the gathering of molecular insights critical for understanding the mechanisms underlying kidney graft tolerance. With this knowledge, trained machine learning procedures can ultimately be utilized for making prognoses or diagnoses about kidney transplantations to improve patient outcomes—all from just the patient’s blood sample.

The transcriptome is highly dynamic and sensitive to environmental conditions, and RNA profiling enables real-time profiling of the RNAs expressed at the time of sample collection. From RNA profiling, information on which biological pathways are active may be deduced by measuring the amount of RNAs corresponding to genes or regulatory RNAs known to be involved in the pathways. RNA sequencing is a powerful technology that is highly sensitive and provides realtime information about the systems and cellular signaling affecting the transplant beyond just the immune system.

This can be invaluable to physicians during their management of patients undergoing kidney transplantation. For example, performing RNA profiling of a patient prior to kidney transplantation may provide insights on the tendency for a patient’s immune system to attack a graft and help guide immunosuppressant therapy dose levels and other related decisions. Profiling of a patient following a kidney transplant may offer realtime insights into their biological responses and signs of damage, such as inflammation, which gives clinicians actionable data to guide their patient’s treatment plan! Importantly, RNA profiling may serve as a more sensitive method of detecting damage that would have gone undetected otherwise and is important for both short- and long-term damage assessments. It is expected that RNA profiling of patients throughout their kidney transplant journey will provide important information that supports successful outcomes.

OFFICE & LABORATORY ADDRESS:
393 Nichol Mill Lane, Suite 200
Franklin, TN 37067

info@vericidx.com

REGISTERED OFFICE:
Avon House
19 Stanwell Road
Penarth
Cardiff, CF64 2EZ